Pillstats
Rx only · Tablet, Delayed Release · Oral

Mesalamine

Brands: Lialda · Mesalamine

17 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US22 NDCs
17 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)52582
US makers17 labelers
Packages31
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 18 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.884$1.77$2.65$3.54Dec 2025Apr 2026Jul 2026
$2.899
Latest avg · Jul 22, 2026
-5%
Since Dec 17, 2025
17
Active US suppliers
29%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

14K28K41K55K2025 Q12025 Q22025 Q32025 Q42026 Q1
43K
Rx · 2026 Q1
5.2M
Units dispensed
-7%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it17 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Takeda Pharmaceuticals America, Inc.unknown5SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown4SUPPLYING
Zydus Lifesciences Limitedunknown4SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING
Camber Pharmaceuticals, Inc.unknown2SUPPLYING
American Health Packagingunknown2SUPPLYING
Chartwell RX, LLCunknown2SUPPLYING
Golden State Medical Supply, Inc.unknown1SUPPLYING
Major Pharmaceuticalsunknown1SUPPLYING
NorthStar RxLLCunknown1SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown1SUPPLYING
Lannett Company, Inc.unknown1SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING
Actavis Pharma, Inc.unknown1SUPPLYING
AvKAREunknown1SUPPLYING

+ 2 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 18, 2024
    RECALLRecall (Class II): Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distributed by: …

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA

  • Oct 28, 2020
    RECALLRecall (Class II): Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis Laboratorie…

    Failed Dissolution Specifications: Out-of-specification dissolution results were obtained during stability testing. — Recalling firm: Teva Pharmaceuticals USA — Nationwide in the U.S. and PR

  • Feb 20, 2020
    RECALLRecall (Class II): Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL,…

    Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing. — Recalling firm: Teva Pharmaceuticals USA — Nationwide in the USA.